John A. Butera

1.3k total citations
38 papers, 945 citations indexed

About

John A. Butera is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John A. Butera has authored 38 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Organic Chemistry and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John A. Butera's work include Cardiac electrophysiology and arrhythmias (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Urinary Bladder and Prostate Research (5 papers). John A. Butera is often cited by papers focused on Cardiac electrophysiology and arrhythmias (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Urinary Bladder and Prostate Research (5 papers). John A. Butera collaborates with scholars based in United States and Canada. John A. Butera's co-authors include Thomas M. Argentieri, N. Wesley Norton, Jeffrey H. Sheldon, Hassan Elokdah, James K. Hennan, Robert E. Swillo, Schuyler Antane, Bradford Hirth, John Dunlop and Eugene L. Piatnitski Chekler and has published in prestigious journals such as Circulation, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

John A. Butera

38 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Butera United States 19 484 312 175 145 74 38 945
Thomas M. Argentieri United States 15 422 0.9× 154 0.5× 139 0.8× 275 1.9× 52 0.7× 34 800
John E. Starrett United States 20 708 1.5× 665 2.1× 321 1.8× 140 1.0× 61 0.8× 38 1.5k
Margot W. Beukers Netherlands 27 1.0k 2.1× 410 1.3× 418 2.4× 77 0.5× 103 1.4× 42 1.9k
Youichi Yabuuchi Japan 18 544 1.1× 298 1.0× 132 0.8× 231 1.6× 127 1.7× 62 1.4k
Rainer Boer Germany 17 444 0.9× 98 0.3× 162 0.9× 68 0.5× 218 2.9× 29 900
Laurie Tota United States 17 598 1.2× 339 1.1× 133 0.8× 39 0.3× 245 3.3× 25 1.1k
Therezinha B. Paiva Brazil 20 628 1.3× 75 0.2× 225 1.3× 256 1.8× 247 3.3× 68 1.1k
Rosanna Matucci Italy 19 567 1.2× 286 0.9× 241 1.4× 84 0.6× 216 2.9× 81 1.1k
George Chiu United States 12 273 0.6× 377 1.2× 123 0.7× 24 0.2× 62 0.8× 42 903
Elsa Anselmi France 20 288 0.6× 584 1.9× 168 1.0× 39 0.3× 82 1.1× 82 1.1k

Countries citing papers authored by John A. Butera

Since Specialization
Citations

This map shows the geographic impact of John A. Butera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Butera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Butera more than expected).

Fields of papers citing papers by John A. Butera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Butera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Butera. The network helps show where John A. Butera may publish in the future.

Co-authorship network of co-authors of John A. Butera

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Butera. A scholar is included among the top collaborators of John A. Butera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Butera. John A. Butera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pu, Jun, Kangwen Deng, John A. Butera, et al.. (2010). De novo synthesis of teleocidin B analogs. Tetrahedron. 66(11). 1963–1972. 5 indexed citations
2.
Butera, John A., et al.. (2010). Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(7). 2163–2167. 36 indexed citations
3.
Rossman, Eric I., Kun Liu, Robert E. Swillo, et al.. (2009). The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model. Journal of Pharmacology and Experimental Therapeutics. 329(3). 1127–1133. 48 indexed citations
4.
Heinrich, Julia, John A. Butera, Angela Krämer, et al.. (2009). Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists. European Journal of Pharmacology. 605(1-3). 53–56. 83 indexed citations
5.
Chekler, Eugene L. Piatnitski, John A. Butera, Li Di, et al.. (2009). Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents. Bioorganic & Medicinal Chemistry Letters. 19(16). 4551–4554. 8 indexed citations
6.
Butera, John A., Bjarne Due Larsen, James K. Hennan, et al.. (2009). Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)13, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation. Journal of Medicinal Chemistry. 52(4). 908–911. 35 indexed citations
7.
Butera, John A., Magid Abou‐Gharbia, Hong Chen, et al.. (2009). Prodrugs of Perzinfotel with Improved Oral Bioavailability. Journal of Medicinal Chemistry. 52(3). 771–778. 27 indexed citations
8.
Berrodin, Thomas J., Scott A. Jelinsky, Nilsa Graciani, et al.. (2008). Novel progesterone receptor modulators with gene selective and context-dependent partial agonism. Biochemical Pharmacology. 77(2). 204–215. 18 indexed citations
9.
Hennan, James K., Robert E. Swillo, James C. Keith, et al.. (2006). Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs. Journal of Pharmacology and Experimental Therapeutics. 317(1). 236–243. 71 indexed citations
10.
Butera, John A., et al.. (2005). Synthesis and bladder smooth muscle relaxing properties of substituted 3-amino-4-aryl-(and aralkyl-)cyclobut-3-ene-1,2-diones. Bioorganic & Medicinal Chemistry Letters. 15(10). 2495–2501. 13 indexed citations
11.
Dunlop, John, H. Beal McIlvain, Brian Jow, et al.. (2005). Characterization of Novel Aryl-Ether, Biaryl, and Fluorene Aspartic Acid and Diaminopropionic Acid Analogs as Potent Inhibitors of the High-Affinity Glutamate Transporter EAAT2. Molecular Pharmacology. 68(4). 974–982. 45 indexed citations
12.
Hennan, James K., Hal S. Feldman, Robert E. Swillo, et al.. (2005). ZP123 Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs. 4 indexed citations
13.
14.
Zhang, Meiyi, Edward H. Kerns, Oliver J. McConnell, et al.. (2003). Brain and plasma exposure profiling in early drug discovery using cassette administration and fast liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 34(2). 359–368. 15 indexed citations
15.
Butera, John A., et al.. (2003). Convenient synthesis of functionalized terphenyls. Tetrahedron Letters. 44(13). 2729–2732. 17 indexed citations
16.
Elokdah, Hassan, Magid Abou‐Gharbia, John A. Butera, et al.. (2003). Design, Synthesis, and Biological Evaluation of Thio-Containing Compounds with Serum HDL-Cholesterol-Elevating Properties. Journal of Medicinal Chemistry. 47(3). 681–695. 39 indexed citations
17.
Butera, John A., Schuyler Antane, Bradford Hirth, et al.. (2001). Synthesis and potassium channel opening activity of substituted 10H-Benzofuro[3,2-b]indole- and 5,10-Dihydro-indeno[1,2-b]indole-1-carboxylic acids. Bioorganic & Medicinal Chemistry Letters. 11(16). 2093–2097. 62 indexed citations
18.
Butera, John A. & Thomas M. Argentieri. (2000). KCO-616. Drugs of the Future. 25(3). 239–239. 5 indexed citations
19.
Butera, John A., et al.. (1991). Synthesis and selective class III antiarrhythmic activity of novel N-heteroaralkyl-substituted 1-(aryloxy)-2-propanolamine and related propylamine derivatives. Journal of Medicinal Chemistry. 34(11). 3212–3228. 24 indexed citations
20.
Butera, John A., Jehan F. Bagli, Wendel W. Doubleday, et al.. (1989). Computer assisted design and synthesis of novel aldose reductase inhibitors. Journal of Medicinal Chemistry. 32(4). 757–765. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas M. Argentieri Breakdown of academic impact, for papers by John E. Starrett Breakdown of academic impact, for papers by Margot W. Beukers Breakdown of academic impact, for papers by Youichi Yabuuchi Breakdown of academic impact, for papers by Rainer Boer Breakdown of academic impact, for papers by Laurie Tota Breakdown of academic impact, for papers by Therezinha B. Paiva Breakdown of academic impact, for papers by Rosanna Matucci Breakdown of academic impact, for papers by George Chiu Breakdown of academic impact, for papers by Elsa Anselmi
Rankless by CCL
2026